Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Growth, recognition, results—and an important partnership
Posted on January 17th, 2019 by admin in Pharma R&D
Here at Sigilon Therapeutics, we have had a very exciting period of growth recently, including receiving an Advanced Therapy Medicinal Product (ATMP) designation from the European Medicines Agency, adding two new members to our leadership team and initiating a collaboration with Eli Lilly in type 1 diabetes. Continue reading “Growth, recognition, results—and an important partnership” »